The SJP Ultrasonics IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 30 September 2026. The SJP Ultrasonics IPO closed on 5 October 2026, with an issue price of ₹67 per share. The SJP Ultrasonics IPO has a face value of ₹10 and a lot size of 2,000 shares. The SJP Ultrasonics IPO size aggregates up to ₹23 crore, listing on BSE SME on 8 October 2026. The SJP Ultrasonics IPO allotment was scheduled for 6 October 2026.
On the financial front, the SJP Ultrasonics IPO reported revenue of ₹27 crore for 31 Mar 2026, compared with ₹21 crore for 31 Mar 2025. The SJP Ultrasonics IPO PAT was ₹5 crore against ₹4 crore. The SJP Ultrasonics IPO EBITDA stood at ₹8 crore with a 32.47% margin. The SJP Ultrasonics IPO net worth as of 31 Mar 2026 was ₹20 crore.
Always verify The SJP Ultrasonics IPO details and GMP data with the official offer document before investing in the SJP Ultrasonics IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
35
27
17
Revenue
27
21
15
PAT
5
4
3
EBITDA
8
7
5
Net Worth
20
15
7
Reserves
11
5
6
Total Borrowing
6
2
2
SJP Ultrasonics IPO Financials FAQs
Revenue of SJP Ultrasonics (Amount in ₹ Crore) — 31 Mar 2026: 27; 31 Mar 2025: 21; 31 Mar 2024: 15. Profit after tax (PAT) — 31 Mar 2026: 5; 31 Mar 2025: 4; 31 Mar 2024: 3.
EBITDA of SJP Ultrasonics (Amount in ₹ Crore) — 31 Mar 2026: 8; 31 Mar 2025: 7; 31 Mar 2024: 5. The EBITDA margin is 32.47%.
Total assets — 31 Mar 2026: 35; 31 Mar 2025: 27; 31 Mar 2024: 17. Net worth — 31 Mar 2026: 20; 31 Mar 2025: 15; 31 Mar 2024: 7. Reserves & surplus — 31 Mar 2026: 11; 31 Mar 2025: 5; 31 Mar 2024: 6. (Amount in ₹ Crore)
Total borrowing of SJP Ultrasonics (Amount in ₹ Crore) — 31 Mar 2026: 6; 31 Mar 2025: 2; 31 Mar 2024: 2. Debt-to-equity ratio: 0.16.
The financials shown for SJP Ultrasonics IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
